PRESS RELEASE
| Acquisitions Contact: | Media Contact: | |||
| Mark D. Engstrom EVP — Acquisitions Healthcare Trust of America, Inc. 480.998.3478 markengstrom@htareit.com | Claire Koeneman President Financial Relations Board 312.640.6745 ckoeneman@mww.com |
Healthcare Trust of America, Inc. Executes Agreement to Acquire the
Triad Technology Center in Baltimore, Maryland
Scottsdale, Arizona (February 10, 2010) – Healthcare Trust of America, Inc. (“HTA”), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire the approximately 101,400 square foot Triad Technology Center in Baltimore, Maryland for approximately $29,250,000. The closing of the acquisition is subject to the satisfaction of a number of conditions.
The building, which is located on the Johns Hopkins University Bayview Medical Center Research Campus, is 100% leased to the U.S. Government and primarily occupied by the National Institutes of Health (“NIH”). The Bayview campus is a 130 acre site that is home to the Johns Hopkins University Medical Center and is ten minutes from downtown Baltimore. The building houses three NIH groups including the National Institute on Aging’s Intramural Research Program, the National Institute on Drug Abuse, and the National Human Genome Research Institute.
“This is an opportunity to acquire a unique asset that supports federal research on healthcare issues facing our society today,” stated Mark D. Engstrom, HTA’s Executive Vice President of Acquisitions. “This acquisition is our second in the Baltimore/Washington D.C. marketplace and we continue to look for strategic opportunities to partner with strong healthcare organizations.”
For more information on Healthcare Trust of America, Inc. and to download the current prospectus, please visitwww.htareit.com.
About Healthcare Trust of America, Inc.
Healthcare Trust of America, Inc. is a self-managed, publicly registered, non-traded, real estate investment trust. In 2009, HTA acquired approximately $494 million in medical office and healthcare-related assets. These assets include a total of 13 properties and one other real estate-related asset, representing approximately 2.3 million square feet. Since its formation in 2006, HTA has made 53 geographically diverse acquisitions valued at approximately $1.46 billion based on purchase price, which includes 179 buildings and two other real estate-related assets. HTA’s portfolio totals approximately 7.4 million square feet, and includes 160 medical office buildings, six hospitals, nine skilled nursing and assisted living facilities and four other office buildings located in 21 states, including: Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Kansas, Maryland, Minnesota, Missouri, New Hampshire, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia and Wisconsin.
1
FORWARD-LOOKING LANGUAGE
This press release contains certain forward-looking statements with respect to the growth and value of HTA’s portfolio and the value that the building adds to HTA. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, but are not limited to, the following: the acquisition of the building may not be completed if the conditions to closing are not satisfied; the strength and financial condition of the building; the strength and financial condition of the tenants; uncertainties relating to the local economies of Baltimore, Maryland; uncertainties relating to changes in general economic and real estate conditions; uncertainties regarding changes in the healthcare industry; the uncertainties relating to the implementation of HTA’s investment strategy; and other risk factors as outlined in HTA’s prospectus, as amended from time to time, and as detailed from time to time in HTA’s periodic reports, as filed with the Securities and Exchange Commission.
2